Layer Slider

Slide backgroundSlide thumbnail
Slide backgroundSlide thumbnail
Slide backgroundSlide thumbnail

Slide backgroundTeamTeamTeam
Slide backgroundResearch TextResearch Text
Slide backgroundSlide thumbnail

Slide backgroundCell2Cell2
Slide backgroundVision1
Slide backgroundVideo2Video2

Research

Research

NewsPage

Clinical Support

Latest News

ICON L

Lipoprotein(A) And Vitamin C Impair Development Of Breast Cancer Tumors In Lp(A)+; Gulo-/- Mice

John Cha*, M. Waheed Roomi*, Tatiana Kalinovsky, Aleksandra Niedzwiecki, Matthias Rath

*Contributed equally

Dr. Rath Research Institute, Santa Clara, California, USA
International Journal of Oncology    2016, 49(3), 895-902

 

Abstract:
Cancer progression is characterized by loss of extracellular matrix (ECM) integrity, which is a precondition for tumor growth and metastasis. In order to elucidate the precise mechanisms of ECM degradation in cancer we used a genetically modified mouse mimicking two distinct human metabolic features associated with cancerogenesis - the lack of endogenous vitamin C synthesis and the production of human Lp(a).  Female Lp(a)+;Gulo(-/-) and control wild type Balb/c mice without these two metabolic features were orthotopically inoculated with 4T1 breast cancer cells (5x105).

The transgenic and control mice were divided into 4 different dietary groups in respect to dietary vitamin C intake: A) low ascorbate intake for 6 weeks; B) high ascorbate intake for 6 weeks; C) low ascorbate intake for 3 weeks followed by high ascorbate for 3 weeks; D) high ascorbate intake for 3 weeks followed by low ascorbate for 3 weeks. After 6 weeks, all wild type mice developed tumors. In contrast, Lp(a)+;Gulo(-/-) mice developed one third less primary tumors (low ascorbate diet) or no primary tumors at all (high ascorbate diet). Significantly, tumors from Lp(a)+;Gulo(-/-) mice immunostained positively for Lp(a) and their size was inversely proportional to Lp(a) serum levels. The results implicate that Lp(a) may play a role in controlling tumor growth and expansion. The most likely mechanism is the competitive inhibition of plasmin-induced ECM degradation due to the homology of Lp(a) components to plasminogen, The confirmation of thispathomechanism could lead to a universal therapeutic target for the prevention and treatment of cancer.

Running title: Lp(a) and vitamin C inhibit breast cancer

Key Words: lipoprotein(a), Lp(a)+;Gulo (-/-) mice, vitamin C, 4T1 breast cancer cells, tumor growth, metastasis

Full Study:

study